insights_auto
Outlook: 18.2% bullish·27.3% bearish
Go to analysischevron_right
BSX:NYSE
Boston Scientific Corp
$42.19
arrow_downward
-0.57%(-0.24) 1D
$42.22
arrow_upward
+0.07% (+0.030)bedtimeAfter hours
Closed: Oct 6, 4:00:05 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BSX...
Open
$42.47
High
$42.75
Low
$42.00
Mkt. cap
61.43B
Avg. vol.
20.59M
Volume
12.55M
P/E ratio
17.11
52-wk high
$105.65
52-wk low
$41.94
EPS
$2.47
Beta
0.58
Shares outstanding
1.45B
No. of employees
59K
Open
$42.47
High
$42.75
Low
$42.00
Mkt. cap
61.43B
Avg. vol.
20.59M
Volume
12.55M
P/E ratio
17.11
52-wk high
$105.65
52-wk low
$41.94
EPS
$2.47
Beta
0.58
Shares outstanding
1.45B
No. of employees
59K
News stories
From web sources and news partners
TipRanks
·
39 minutes ago
Boston Scientific Stock Stumbles as Wall Street Turns Wary
Royal Gazette | Bermuda
·
2 hours ago
Three companies trade on BSX
AD HOC NEWS
·
7 hours ago
Boston Scientific stock heads toward an October 28 outlook reset in 2026
Zacks
·
7 hours ago
Can J&J's MedTech Business Rebound in Q3 After Q2 Slowdown?
Profile
Boston Scientific Corporation is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
The company is known for developing the Taxus Stent, a drug-eluting stent that is used to open clogged arteries.
BSC is headquartered in Marlborough, Massachusetts and incorporated in Delaware. Wikipedia
About Boston Scientific Corp
CEOMichael F. Mahoney
Employees59K
FoundedJun 29, 1979
HeadquartersMarlborough, Massachusetts, United States
SectorMedical device
Websitebostonscientific.com